Brazilian Market – Medical Cannabis Regulatory Overview

by Pedro Felipe Raymundo - GMP Compliance Executive Consultant @PQE Group

Like the rest of the world, the main challenge for the Brazilian legal cannabis market is to know its real size and growth potential. Countless variables must be considered in this equation, whose predominant factor is the inescapable law of supply and demand. Recent news shows us a veritable invasion of cannabis brands and products aimed at patients in Brazil. 

Brazilian Market_legislative_sito PQE

Anvisa's RDC 327/2019 was the resolution responsible for establishing the criteria for granting the authorization for the import, manufacture, commercialization, prescription and dispensing of cannabis products for medicinal purposes in Brazil. Therefore, it is necessary to use a step-by-step approach to obtain the license and commercialize the product.

Read the full article on GQC website

Want to know more?

Visit GQC - Glocal Quality Cannabis website, our Medical Cannabis dedicated company


Our experts can support you through every stage of cultivation and extraction.
We will make sure you fully meet the compliance standards set in your country for greenhouses and laboratories and we will help you register your product and sell it in different countries.

Connect with us